Seres Therapeutics (NASDAQ: MCRB) is a microbiome therapeutics company developing a novel class of multifunctional bacterial consortia that interact with host cells and tissues to treat disease.
Seres SER-109 is the companys lead clinical candidate and…
Is Seres Therapeutics Still A Buy After Disappointing SER-287 Topline Results?
Share this article
More News
How XRP Price Is Navigating War Volatility in 2026
April 1, 2026
SI 토큰과 SIREN 토큰 급락 차이 완벽 분석
April 1, 2026
Prediction: This Will Be Palantir’s Stock Price in 2030
April 1, 2026
